This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
Charles Carusi
Vice President
Contact
CharlesCarusi@mmmukg.comOverview
Charles Carusi, PhD, is a Vice President for Behavioral Health and Health Policy Practice Area, where he leads the tobacco studies group. Despite considerable gains in reducing the health and economic burdens of tobacco use, it remains the leading cause of preventable death and disease. Carusi focuses on applying research methods and tobacco regulatory science to inform public health policy and practice in regard to tobacco products and their use.
The research spans the areas of tobacco surveillance, epidemiology, tobacco use prevention and cessation, tobacco control program evaluation, biological research, and policy support. This research supports numerous federal, state, and international agencies, foundations, and academic institutions.
Education
- PhD, Theatre Research, Tufts University
- MA, Theatre, Northwestern University
- BA, English (with minors in Physics and Mathematics), Thomas More College
Areas of Expertise
Behavioral Health Health Services Research and Health Policy Tobacco Survey Design-
Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk
55,
Nature Genetics
January 2023
N. Shrine, A.G. Izquierdo, J. Chen, R. Packer, R.J. Hall, A.L. Guyatt, C. Batini, et al.
DOILink for: Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk -
Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study indicators of tobacco dependence using biomarkers of nicotine exposure across tobacco products
24,
Nicotine and Tobacco Research
January 2022
D.R. Strong, E. Leas, M. Noble, M. White, A. Glasser, Kristie Taylor, K.C. Edwards, et al.
DOILink for: Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study indicators of tobacco dependence using biomarkers of nicotine exposure across tobacco products -
National longitudinal tobacco product cessation rates among US adults from the PATH Study: 2013–2019 (waves 1–5)
Tobacco Control
January 2022
K.A. Kasza, Z. Tang, H. Xiao, D. Marshall, C. Stanton, A.L. Gross, K.M. Jackson, et al.
DOILink for: National longitudinal tobacco product cessation rates among US adults from the PATH Study: 2013–2019 (waves 1–5)